Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
International journal of environmental research and public health · 2022 Jul 16
Abstract
The life expectancy of the population is increasing worldwide due to improvements in the prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 diabetes mellitus (T2DM) in the elderly. Sarcopenia and frailty are also frequently present in aging. These three entities share common mechanisms such as insulin resistance, chronic inflammation, and mitochondrial dysfunction. The coexistence of these situations worsens the prognosis of elderly patients. In this paper, we review the main measures for the prevention and management of sarcopenia and/or frailty in elderly patients with T2DM.
Neurotransmitters
None linked yet.
Related
Ratings (0): Breadth — · Depth — · Enjoyment — · Usefulness —
Community
Log in to rate and share your notes.
No contributions yet.